Stock Fundamentals

Company Information

▼
Company Name
NewAmsterdam Pharma Company N.V. Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: NL00150012L7
CIK: 0001936258
Currency: USD
Full Time Employees: 100
Phone: 31 35 206 2971
Website: https://www.newamsterdampharma.com
Fiscal Year End: December
IPO Date: Nov 23, 2022
Description:

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Address:

Gooimeer 2-35, Naarden, Netherlands, 1411 DC

Directors & Officers

▼
Name Title Year Born
Dr. Michael Harvey Davidson FACC, Facp., M.D. CEO, President & Executive Director 1956
Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D. Founder, Chief Scientific Officer, Member of Executive Board & Director 1954
Mr. Mayur Amrat Somaiya Chief Financial Officer 1974
Mr. Douglas F. Kling Chief Operating Officer 1973
Ms. Louise Kooij Chief Accounting Officer 1976
Mr. Matthew Philippe Executive VP &Head of Investor Relations NA
Mr. Bob Rambo Executive Vice President of Marketing NA
Ms. Maryellen McQuade Chief People Officer NA
Ms. Juliette Audet M.B.A., M.Sc. Chief Strategy & Business Officer 1987
Dr. Marc Ditmarsch M.D. Chief Development Officer 1967

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Frazier Life Sciences Management, L.P. 16.94M Dec 31, 2025 14.74% $15.96 1.45%
Capital World Investors 9.82M Sep 30, 2025 8.54% $0.04 17.11%
RA Capital Management, LLC 9.55M Dec 31, 2025 8.31% $3.43 -5.81%
FCPM III SERVICES BV 9.21M Sep 30, 2025 8.01% $52.36 -13.35%
Bain Capital Life Sciences Investors, LLC 7.31M Dec 31, 2025 6.35% $19.63 -31.84%
FMR Inc 6.41M Dec 31, 2025 5.58% $0.01 15.86%
Wellington Management Company LLP 5.03M Dec 31, 2025 4.38% $0.03 25.20%
Viking Global Investors LP 4.20M Dec 31, 2025 3.66% $0.39 -35.09%
Deerfield Management Co 4.16M Dec 31, 2025 3.62% $1.87 -2.39%
Jennison Associates LLC 3.49M Dec 31, 2025 3.03% $0.07 -16.89%
Duquesne Family Office LLC 3.07M Dec 31, 2025 2.67% $2.40 59.60%
Polar Capital Holdings PLC 2.91M Sep 30, 2025 2.53% $0.40 15.64%
Medicxi Ventures Management (Jersey) Ltd 2.87M Dec 31, 2025 2.50% $12.06 0.00%
JPMorgan Chase & Co 2.60M Sep 30, 2025 2.27% $0.00 78.56%
Cormorant Asset Management, LLC 2.18M Sep 30, 2025 1.89% $4.27 0.00%
AllianceBernstein L.P. 2.14M Sep 30, 2025 1.86% $0.02 -8.14%
HHG PLC 2.12M Sep 30, 2025 1.84% $0.03 7.90%
Capital Research & Mgmt Co - Division 3 2.06M Sep 30, 2025 1.79% $0.01 0.00%
Maverick Capital Ltd 1.50M Sep 30, 2025 1.31% $0.57 -1.77%
Morgan Stanley - Brokerage Accounts 1.50M Sep 30, 2025 1.30% $0.00 134.82%

Shares Statistics

▼
Shares Outstanding: 114.98M
Shares Float: 69.23M
% Insiders: 97.20%
% Institutions: 10,621.10%
Short % Float: 7.18%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Frazier Life Sciences Management, L.P. 16.94M 14.74% ▲ 1.45% Dec 31, 2025
2 Capital World Investors 9.82M 8.54% ▲ 17.11% Sep 30, 2025
3 RA Capital Management, LLC 9.55M 8.31% ▼ 5.81% Dec 31, 2025
4 FCPM III SERVICES BV 9.21M 8.01% ▼ 13.35% Sep 30, 2025
5 Bain Capital Life Sciences Investors, LLC 7.31M 6.35% ▼ 31.84% Dec 31, 2025
6 FMR Inc 6.41M 5.58% ▲ 15.86% Dec 31, 2025
7 Wellington Management Company LLP 5.03M 4.38% ▲ 25.20% Dec 31, 2025
8 Viking Global Investors LP 4.20M 3.66% ▼ 35.09% Dec 31, 2025
9 Deerfield Management Co 4.16M 3.62% ▼ 2.39% Dec 31, 2025
10 Jennison Associates LLC 3.49M 3.03% ▼ 16.89% Dec 31, 2025

Valuation Metrics

▼
Enterprise Value: $3.44B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $4.08B
EBITDA: $-225.46M
Book Value: $5.97
Earnings/Share: $-1.72
Profit Margin: 0.00%
Operating Margin: -206,187.50%
ROA (TTM): -17.27%
ROE (TTM): -28.29%
Revenue (TTM): $22.50M
Revenue/Share (TTM): $0.19
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -99.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 7.88x 0.00x 0.11x N/A 0.00x
2024-12-31 8.08x 0.00x 0.12x N/A 0.00x
2023-12-31 6.95x 0.00x 0.17x -26.91x 0.00x
2022-12-31 13.26x 0.00x 0.10x -12.39x 0.00x
2021-12-31 5.96x 0.00x 0.17x -85.10x 0.00x
2020-12-31 7.90x 0.09x 0.09x -19.28x -1.76x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 26, 2026 Michael H Davidson N/A Sale 183.33K $33.71 $6.18M
Feb 25, 2026 Michael H Davidson N/A Sale 58.25K $35.30 $2.06M
Feb 24, 2026 Michael H Davidson N/A Sale 64.71K $36.15 $2.34M
Feb 20, 2026 Johannes Jacob Piete Kastelein N/A Sale 45.48K $35.31 $1.61M
Jan 28, 2026 Louise Frederika Kooij N/A Sale 32.61K $31.80 $1.04M
Jan 27, 2026 Louise Frederika Kooij N/A Sale 39.82K $32.62 $1.30M
Jan 26, 2026 Louise Frederika Kooij N/A Sale 34.40K $32.78 $1.13M
Jan 23, 2026 Louise Frederika Kooij N/A Sale 38.17K $33.75 $1.29M
Jan 05, 2026 Johannes Jacob Piete Kastelein N/A Sale 6.00K $33.25 $199.50K
Jan 05, 2026 Louise Frederika Kooij N/A Sale 2.65K $33.25 $88.01K
Dec 26, 2025 Louise Frederika Kooij N/A Sale 43.87K $35.30 $1.55M
Dec 24, 2025 Louise Frederika Kooij N/A Sale 26.01K $35.68 $928.07K
Dec 23, 2025 Louise Frederika Kooij N/A Sale 75.12K $36.21 $2.72M
Sep 15, 2025 James N Topper N/A Purchase 660.00 $23.70 $15.64K
Sep 09, 2025 Louise Frederika Kooij N/A Sale 150.00K $25.83 $3.87M
Sep 08, 2025 James N Topper N/A Purchase 1.26K $24.99 $31.49K
Sep 03, 2025 Louise Frederika Kooij N/A Sale 18.07K $25.09 $453.45K
Aug 25, 2025 Louise Frederika Kooij N/A Sale 8.27K $24.86 $205.57K
Aug 21, 2025 Johannes Jacob Piete Kastelein N/A Sale 50.00K $24.29 $1.21M
Aug 11, 2025 James N Topper N/A Purchase 471.00 $23.98 $11.29K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NAMS.US!